Exposure to relatively bright daytime light is linked to lower dementia risk and may provide a novel, measurable method to identify individuals at high risk for dementia.

The same drugs that transformed obesity treatment are now being investigated for substance use disorders, fueling interest in ...

In patients with newly diagnosed epilepsy, nearly 70% of seizure relapses are linked to potentially modifiable factors, including poor adherence and inadequate ASM dosing, rather than drug resistance.

Experts urge clinicians to look beyond skin changes, recognizing that stigma, depression, and delayed diagnosis continue to ...

Emerging evidence suggests that gut biotics may help reduce inflammation and improve psoriasis severity, but larger studies ...

The Medicare GLP-1 Bridge will start July 1. Regardless of the balance sheet, the responsible choice, says Dr Amy Faith Ho, is not to wait until obesity becomes a heart attack, a dialysis chair, or ...

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

In 19th-century France, hypnosis moved from medical experiment to public spectacle, reshaping debates over mind, body, and control.

A Spanish trial finds positional therapy improves positional sleep apnea, is better tolerated than CPAP, and maintains benefits in many patients after treatment ends.

The absolute risk appears low, but new data suggest small changes in smell and taste with GLP-1 treatment may exceed those already associated with type 2 diabetes.

Topical ivermectin and encapsulated benzoyl peroxide improve inflammatory lesions and severity compared with metronidazole in studies of patients with moderate-to-severe rosacea.

Prescription rates for attention-deficit/hyperactivity disorder medications are rising sharply in Poland, with the fastest increases seen among young adults, particularly women.